[Other] The Neutrophil-to-Lymphocyte Ratio during Atezolizumab plus Bevacizumab Therapy for Unresectable Hepatocellular Carcinoma Predicts Long-Term Therapeutic Efficacy: A Multicenter Analysis

noona Post time 5 day(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-06-22 19:32
Reward20points

journalㄩOncology

AuthorsㄩRyo Sato; Takanori Suzuki; Kentaro Matsuura; Daisuke Kato; Katsumi Hayashi; Kohei Okayama; Fumihiro Okumura; Satoshi Sobue; Atsunori Kusakabe; Izumi Hasegawa; Kiyoto Narita; Tsutomu Mizoshita; Yoshihide Kimura; Hiromu Kondo; Hisayo Kojima; Kazuki Hayashi; Atsushi Ozasa; Hayato Kawamura; Kei Fujiwara; Shunsuke Nojiri; Hiromi Kataoka;  

Published dateㄩ--

DOIㄩ10.1159/000547264

PDF linkㄩhttps://karger.com/article-pdf/doi/10.1159/000547264

Article linkㄩhttps://doi.org/10.1159/000547264

Article SourceㄩS. Karger AG


Remarkㄩ

Best Answer

Please approve

View Full Content

Reply

Use magic Donate Report

All Reply1 Show all posts
librarian666 Post time 5 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Return to the list